A Phase 1b/2, Open-Label, Safety and Efficacy Study of Epcoritamab (GEN3013; DuoBody®-CD3 X CD20) in Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter?s Syndrome
Clinical Trial Grant
Awarded By
Genmab US, Inc.
Start Date
December 19, 2023
End Date
December 30, 2028
Awarded By
Genmab US, Inc.
Start Date
December 19, 2023
End Date
December 30, 2028